Vivos Therapeutics, Inc. Proceeds from Issuance of Warrants
Vivos Therapeutics, Inc. (VVOS) reported Proceeds from Issuance of Warrants of $1.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-08-14
- Vivos Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2026-06-30 was $995.00K.
- Vivos Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2026-03-31 was $567.00K.
- Vivos Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2025-12-31 was $0.00.
- Vivos Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2025-09-30 was $0.00.
- Vivos Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2025 was $1.70M, a 77.35% decline from fiscal 2024.
- Vivos Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2024 was $7.50M.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|
| 2026-06-30 | $995.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.56M 10-Q · filed 2026-08-14 | $1.56M derived: sum of 3 quarters · filed 2026-08-14 | $1.56M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $567.00K 10-Q · filed 2026-05-20 | $567.00K derived: sum of 2 quarters · filed 2026-05-20 | $567.00K derived: sum of 3 quarters · filed 2026-05-20 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $0.00 derived: sum of 2 quarters · filed 2026-04-15 | $1.70M 10-K · filed 2026-04-15 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $1.70M 10-Q · filed 2025-11-19 | ||
| 2025-06-30 | $1.70M 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $7.50M 10-K · filed 2026-04-15 | ||
| 2024-09-30 | $7.50M 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |